tirzepatide diabetes trial New research from the SURPASS-EARLY found that improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 Tirzepatide's Surmount-4 Trial Reveals Groundbreaking

Benefits include better sleep, faster recovery, improved body composition, and healthier skin

It occupies 75-85% of folate receptors without delivering benefit, preventing natural folate entry

These medications work through different mechanisms and carry distinct safety profiles that require careful consideration

It targets the four core pillars of GLP-1-related aging: Deflation, Deep Wrinkles, Dehydration, and Density Loss, giving your skin the support it needs to adapt, strengthen, and bounce back

GABA helps calm down the nervous system by reducing activity in the brain

In clinical trials, average weight loss was roughly 13% to 17% of starting body weight over ~6468 weeks